First Foundation Advisors Fulgent Genetics, Inc. Transaction History

First Foundation Advisors

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$47.98 - $62.75 $226,849 - $296,682	-4,728 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$74.87 - $110.87 $13,626 - $20,178	182 Added 4.0%	4,728 $425,000
Q2 2021 Aug 13, 2021	BUY	$66.8 - $100.45 $13,226 - $19,889	198 Added 4.55%	4,546 $419,000
Q1 2021 May 18, 2021	BUY	$59.3 - $183.85 $257,836 - $799,379	4,348 New	4,348 $420,000

201

16.1M

2.04M

14K

Ticker FLGT
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 30,265,800
Market Cap $592M
Description
Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...

Get notified when there are updates to the investment portfolio of First Foundation Advisors, based on Form 13F filings with the SEC.

Stay updated on First Foundation Advisors with notifications on news.